Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

[Lewandowsky-Lutz epidermodysplasia verruciformis associated with vitiligo].

Abal'iants LA, Talanin NIu.

Vestn Dermatol Venerol. 1988;(4):63-5. Russian. No abstract available.

PMID:
3414173
2.

Failure of etretinate in epidermodysplasia verruciformis.

Kowalzick L, Mensing H.

Dermatologica. 1986;173(2):75-8.

PMID:
3792602
3.

Follow-up of patients with epidermodysplasia verruciformis treated with etretinate.

Jablonska S, Obałek S, Wolska H.

Dermatologica. 1986;173(4):196-9. No abstract available.

PMID:
3021547
4.

[Lewandowsky-Lutz epidermodysplasia verruciformis. Considerations on 2 cases in adults].

Bertani E, Gasparini G, Podenzani S, Sambvani N, Guidarelli C.

G Ital Dermatol Venereol. 1983 Sep-Oct;118(5):305-10. Italian. No abstract available.

PMID:
6321331
5.

[Epidermodysplasia verruciformis-like genodermatosis with changes in the nails].

Salamon T, Halepović E, Berberović L, Nikulin A, Lazović-Tepavac O, Cerkez A, Basić V.

Hautarzt. 1987 Sep;38(9):525-31. German.

PMID:
3692854
6.

What is the evidence for effective treatments of acquired epidermodysplasia verruciformis in HIV-infected patients?

Lee KC, Risser J, Bercovitch L.

Arch Dermatol. 2010 Aug;146(8):903-5. doi: 10.1001/archdermatol.2010.194. No abstract available.

PMID:
20713825
7.

[Anatomo-clinical, immunological and developmental profile of Lewandowsky-Lutz epidermodysplasia verruciformis. Literature review apropos of 2 case reports].

Benzarti H, Fazaa B, Mokhtar I, Kharfi M, Goffin V, Piérard GE, Kamoun MR.

Rev Med Liege. 1994 Aug 1;49(8):446-51. Review. French. No abstract available.

PMID:
7939013
8.

[Etretinate and the prevention of skin cancers].

Verret JL.

Ther Umsch. 1986 Sep;43(9):699-702. Review. French. No abstract available.

PMID:
3535154
9.

Acquired epidermodysplasia verruciformis in a patient with congenital HIV infection.

Castro-Perez GA, Sorin I, Bravo AI, Mazzuoccolo LD.

Actas Dermosifiliogr. 2013 Oct;104(8):731-3. doi: 10.1016/j.adengl.2012.10.013. No abstract available.

PMID:
24067256
10.

Epidermodysplasia verruciform-like Lesions in an HIV patient.

Berk DR, Bruckner AL, Lu D.

Dermatol Online J. 2009 Jan 15;15(1):1.

11.

Interferon and retinoid treatment of warts.

Blanchet-Bardon C, Lutzner MA.

Clin Dermatol. 1985 Oct-Dec;3(4):195-9. No abstract available.

PMID:
2463864
12.

Cimetidine therapy for epidermodysplasia verruciformis.

Micali G, Nasca MR, Dall'Oglio F, Musumeci ML.

J Am Acad Dermatol. 2003 Feb;48(2 Suppl):S9-10.

PMID:
12582373
13.

The lack of a clinical effect of cimetidine in the treatment of epidermodysplasia verruciformis.

de Oliveira WR, Neto CF, Rivitti EA.

J Am Acad Dermatol. 2004 Jun;50(6):e14; author reply e15. No abstract available.

PMID:
15153919
14.

[Epidermodysplasia verruciformis caused by HPV 12 virus].

Misiewicz J, Rubisz-Brzezińska J, Jabłońska S.

Przegl Dermatol. 1988 Jul-Aug;75(4):286-92. Polish. No abstract available.

PMID:
2853427
15.

Epidermodysplasia verruciformis: Langerhans cells, immunologic effect of retinoid treatment and cytogenetics.

van Voorst Vader PC, de Jong MC, Blanken R, Kallenberg CG, Vermey A, Scheres JM.

Arch Dermatol Res. 1987;279(6):366-73.

PMID:
3499869
16.

[Lewandosky-Lutz verruciformis epidermodysplasia. Immunologic study and treatment with the aromatic retinoid Ro 10-9359].

Graifemberghi S, Gavazzoni R, Coglio G, Pozzo G.

G Ital Dermatol Venereol. 1982 May-Jun;117(3):191-4. Italian. No abstract available.

PMID:
7187403
17.

Epidermodysplasia verruciformis and human papilloma virus.

Gewirtzman A, Bartlett B, Tyring S.

Curr Opin Infect Dis. 2008 Apr;21(2):141-6. doi: 10.1097/QCO.0b013e3282f486c9. Review.

PMID:
18317036
18.

Epidermodysplasia verruciformis in the setting of HIV infection.

Chen P Jr, Kamino H, Walters RF, Rosenman K, Pomeranz MK, Sanchez M.

Dermatol Online J. 2008 Oct 15;14(10):1.

PMID:
19061600
19.

Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin.

Majewski S, Jabłońska S.

Arch Dermatol. 1995 Nov;131(11):1312-8. Review.

PMID:
7503577
20.

Supplemental Content

Support Center